Clinical trial
A Non-Interventional Clinical Study to Assess the Risk and Performance Aspects of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage
NCT05126407 is registered in ClinicalTrials.gov with Johnson & Johnson Consumer Inc. (J&JCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Non-Interventional Clinical Study to Assess the Risk and Performance Aspects of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage
- Lead sponsor
- Johnson & Johnson Consumer Inc. (J&JCI)
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 17, 2021
- Completion date
- January 20, 2022
- Enrollment
- 87 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.